COVID-19: Two new antiviral treatments recommended by the World Health Organization for specific conditions

COVID-19: What are the five treatments recommended by the World Health Organization and in what cases?

Health crisis – Apart from vaccination, the World Health Organization recommends several treatments to fight COVID-19. But it is only recommended for certain types of patients.

They are now five in number. The list of Covid treatments officially recommended by the World Health Organization (WHO) was already extended on Friday, with the addition of Sotrovimab and Baricitinib. But if the number increases, then the organization’s recommendations relate only to very specific cases. We are evaluating.

All information on

France affected by fifth wave of Covid-19

Ronaprif and sutrovimab for high-risk patients

Synthetic antibody treatments are part of WHO recommendations. First of all, the UN agency has recommended Ronapreve, authorized in France by the High Health Authority, since September 2021. It is especially so for “Patients with non-severe forms of Covid who are at high risk of hospitalization”The World Health Organization said in an advisory report, such as the elderly or those with weakened immune systems.

The second, sotrofimab, has been recommended since Friday in the same cases as Ronaprive. The benefit of this treatment, authorized in France under the name Xevudy, is very low for patients who are not at risk.

But the interest of these two treatments varies, according to the World Health Organization (WHO), in the case of the Omicron variant. “Its efficacy against new variants such as Omicron remains uncertain.”Experts write in an opinion published Friday in the Medical Journal BMJ.

Tocilizumab, Sarilumab and Baricitinib against severe forms

Also recommended are products aimed at blocking interleukin-6 (in order to avoid an uncontrolled immune response), more specifically Tocilizumab and Sarilumab. It is aimed at patients with severe or critical form of Covid-19 and can be combined with corticosteroids, according to the opinion published by the World Health Organization in July 2021.

Baricitinib, a drug commonly used against rheumatoid arthritis that joined the WHO’s list of recommendations on Friday, is recommended for the same patient profile as Tocilizumab and Sarilumab and should also be given In combination with corticosteroids. In patients with a severe form of the virus, it It improves survival rates and reduces the need for mechanical ventilation. WHO notes.

Corticosteroids against severe forms of the virus

For corticosteroids, the World Health Organization suggests using them since September 2020 “In the case of patients with severe or critical form of COVID-19”. On the other hand, the organization advises against administering For the treatment of patients with a non-severe form.

Read also

  • COVID-19: Two new antiviral treatments recommended by the World Health Organization for specific conditions
  • COVID-19: Are Millions of Tests a Week Still Helpful?

WHO recommendations for anti-Covid therapy are regularly updated based on clinical trials conducted on different types of patients. In recent months, the organization has refused to use several treatments such as plasma injections for recovered Covid patients, ivermectin and hydroxychloroquine.

about the same topic

Most Read Articles

Exclusive – Presidency 2022: Find out the results of our daily poll for January 14

Students with disabilities: Eric Zemmour’s proposal sparks new controversy

Partigate in the United Kingdom: “Boris Johnson’s resignation is just days”

Covid-19: 3 questions about health deactivation pass on Saturday 15 January

COVID-19: How some countries are preparing to end the health crisis

LCI . Logo
Defends the ambition of information
verified Everyone can access it thanks to the income
advertisement .

To help us keep this service free, you can “change your choice” and accept all cookies.


Leave a Comment

Your email address will not be published.